False
September 9, 2025
A surge in inspections, a spike in warning letters, and targeted action against high-risk sectors: the FDA’s 2024 report shows global pharma quality is under sharper scrutiny than ever.
4 min read
September 9, 2025
Researchers call for urgent action to protect the future of mRNA vaccine development
2 min read
September 8, 2025
By predicting how cells repair DNA, researchers find a way to make CRISPR edits more precise.
3 min read
September 8, 2025
As cell and gene therapies become more commonplace, focus has now moved onto manufacturing efficiency and improving access for patients.
15 min read
September 5, 2025
Rocket launcher antibiotics, subscription models, and articulating value; we discuss new progress in antimicrobial therapies with Michael Murray
9 min read
September 5, 2025
Meet the drug-delivery nanoparticles that self-assemble with temperature changes.
3 min read
September 4, 2025
Paul Offit, a longtime FDA advisor and prominent figure in vaccine development, sidelined from vaccine committee amid healthcare turmoil in the US.
2 min read
September 4, 2025
An international steering committee launched earlier in 2025 to improve access to CAR T-cell therapies for cancer patients. A cell therapy research specialist shares her reasons why.
9 min read
September 4, 2025
Increasing demand for GLP-1s sparks surge in illegal distribution
2 min read
September 3, 2025
Experts explain how cell and gene therapies have disrupted the industry and what lies ahead in this sector’s future.
15 min read
False